Can value-based care transform the American healthcare system? In this episode, we dive deep into this pressing question with Dr. Mohamed Diab, president of CVS Accountable Care. Dr. Diab highlights systemic challenges, such as physician burnout and the inadequacies of primary care funding. With an emphasis on primary care's critical role in managing chronic conditions and preventing illness, he reveals how a shift to value-based care can lead to better health outcomes by focusing on holistic, patient-centered approaches that tackle social determinants and behavioral health.

We also address the complexities of this transition, specifically for healthcare executives who are navigating the shift from fee-for-service to value-based models. Learn about Medicare's ambitious plan to achieve 100% value-based care by 2030 and discover how CVS Health's Accountable Care Organization is leveraging technology, analytics, and clinical programs to support providers and Medicare beneficiaries.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

Greg Mario, CEO of TAXIS Pharmaceuticals shares his dynamic journey from a childhood of constant relocations to spearheading the fight against antibiotic-resistant infections. Greg opens up about his immigrant grandparents' profound influence and a transformative experience with a captivating professor at Trinity College that shifted his academic focus from mechanical engineering to chemistry. This pivotal change set the foundation for his career in the pharmaceutical industry, highlighting his adaptability and dedication to human health.

Discover the fascinating evolution of Evogen, a company initially centered on bio and chemical threat detection, which pivoted to tackle central nervous system diseases under Greg's leadership. We also explore the creation of as revolutionary blood-based epilepsy diagnostic test, as well as the pressing issue of antibiotic resistance.

Greg provides a historical perspective on antibiotics and underscores the urgent need for innovative antimicrobial treatments to combat the relentless rise of superbugs, emphasizing the resilience and adaptability required in the healthcare industry.

In the final section, we explore the relentless pursuit of funding in the biotech world through Greg's experiences with TAXIS Pharmaceuticals. Learn about the company's early days and the recent $2.7 million NIH grant for their promising efflux pump inhibitor, now on the brink of human trials.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

Unlock the secrets to effective behavioral health management in long-term care in this interview with Rocco Coniglio, a powerhouse in healthcare entrepreneurship. From a sports-driven childhood in Pittsburgh to collegiate triumphs as a middle linebacker, Rocco's journey is certain to inspire. We dive into his career, navigating roles at McKesson, Gambro, Medtronic, and Spectranetics, and explore his bold move to co-found Psych360 mid-career. Get actionable insights on starting a business while juggling a high-stakes job and learn why a supportive company culture is pivotal for success.

The second half of the episode delves into the complex world of nursing home regulations and the transformative role of telehealth. Discover how CMS rules reshaped medication practices and learn about the importance of advanced practice nurses in long-term care.

We also discuss strategic partnerships with universities to tackle psychiatrist shortages and the game-changing impact of telehealth, especially in rural areas. Tune in for a comprehensive look at the future of healthcare, featuring expert opinions on trends, challenges, and innovative strategies for better health outcomes and operational efficiency.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.